Amphastar Pharmaceuticals, Inc.
AMPH
$17.50
-$0.95-5.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.06% | -38.51% | -29.22% | -19.10% | -8.44% |
| Total Depreciation and Amortization | 10.33% | 10.48% | 9.85% | 9.15% | 20.90% |
| Total Amortization of Deferred Charges | -28.12% | -44.38% | -60.92% | -75.84% | -65.35% |
| Total Other Non-Cash Items | 348.74% | 1,009.45% | -60.40% | 38.45% | -5.76% |
| Change in Net Operating Assets | -41.49% | -353.50% | 2.66% | -64.39% | 23.28% |
| Cash from Operations | -12.58% | -26.84% | -26.87% | -24.90% | -2.64% |
| Capital Expenditure | 21.55% | 15.01% | -2.49% | -37.69% | -14.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | 74.53% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -251.10% | -178.58% | 74.55% | 34.70% | 150.51% |
| Cash from Investing | 24.78% | 43.70% | 76.37% | 68.02% | 79.33% |
| Total Debt Issued | -71.40% | -66.28% | -20.30% | -94.23% | -98.12% |
| Total Debt Repaid | 97.39% | 97.30% | 99.60% | 99.91% | 97.42% |
| Issuance of Common Stock | -- | -- | -75.48% | -91.31% | -- |
| Repurchase of Common Stock | -1.58% | 16.30% | -81.25% | -72.20% | -31.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.12% | 15.81% | 50.56% | 88.91% | 96.11% |
| Cash from Financing | -1.53% | 16.71% | 12.00% | -765.33% | -118.03% |
| Foreign Exchange rate Adjustments | -284.00% | 210.53% | 149.88% | 147.45% | 106.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.52% | 153.90% | 130.69% | -105.00% | -174.86% |